Methamphetamines clinical trials at UCSD

1 in progress, 0 open to eligible people

Showing trials for

  • Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder

    Sorry, not currently recruiting here

    The primary objective of this study is to evaluate the efficacy of extended release naltrexone plus bupropion XL (XR-NTX/BUP-XL) compared to matched injectable and oral placebo (iPLB/oPLB) in reducing methamphetamine (MA) use in individuals with moderate or severe methamphetamine use disorder (MUD) seeking to stop or reduce MA use.

    San Diego, California and other locations

Last updated: